Cargando…
Dabigatran in Cerebral Sinus Vein Thrombosis and Thrombophilia
Background and Purpose: Thrombophilic gene alterations are a major risk factor for cerebral sinus vein thrombosis (CSVT). Up to 30% of all patients with cerebral sinus vein thrombosis (CSVT) are found to have thrombophilic defects such as prothrombin mutation (PTM) or factor V Leiden (FVL). Their re...
Autores principales: | Kellermair, Lukas, Zeller, Matthias W. G., Kulyk, Caterina, Tomasits, Josef, von Oertzen, Tim J., Vosko, Milan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316430/ https://www.ncbi.nlm.nih.gov/pubmed/35888060 http://dx.doi.org/10.3390/life12070970 |
Ejemplares similares
-
Features of Pharmacodynamics of the Anticoagulant Dabigatran in Secondary
Thrombophilia
por: Kairov, Gaisa T., et al.
Publicado: (2018) -
Recurrent Deep Vein Thrombosis due to Thrombophilia
por: Rahman, Afzalur, et al.
Publicado: (2012) -
A Study on the Distinctive Clinical Profile and Thrombophilia in Pediatric Cerebral Venous Sinus Thrombosis
por: Ismail, Nevine, et al.
Publicado: (2021) -
Ad26.COV2-S: Cerebral venous sinus thrombosis and unmasking of inherited thrombophilia: case report
Publicado: (2022) -
Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis
por: Makoto, Ikejiri, et al.
Publicado: (2018)